PAVmed Inc.

DB:1P50 Stok Raporu

Piyasa değeri: €20.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

PAVmed Gelecekteki Büyüme

Future kriter kontrolleri 2/6

PAVmed is forecast to grow earnings and revenue by 24.4% and 49.2% per annum respectively while EPS is expected to grow by 44.5% per annum.

Anahtar bilgiler

24.4%

Kazanç büyüme oranı

44.5%

EPS büyüme oranı

Medical Equipment kazanç büyümesi15.8%
Gelir büyüme oranı49.2%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme09 Dec 2023

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

DB:1P50 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026128-104N/A1
12/31/202529-56-42N/A2
12/31/20248-60-62-124
12/31/20232-68-65-534
9/30/20232-71-57-57N/A
6/30/20231-79-66-65N/A
3/31/20231-90-76-75N/A
12/31/20220-89-73-71N/A
9/30/20221-86-73-71N/A
6/30/20221-72-62-60N/A
3/31/20221-58-46-44N/A
12/31/20211-51-42-41N/A
9/30/20210-42-31-31N/A
6/30/2021N/A-35-29-28N/A
3/31/2021N/A-30-27-27N/A
12/31/2020N/A-35-22-22N/A
9/30/2020N/A-32-19-19N/A
6/30/2020N/A-30-16-16N/A
3/31/2020N/A-28-13-13N/A
12/31/2019N/A-17-13-13N/A
9/30/2019N/A-17-12-12N/A
6/30/2019N/A-17-11-11N/A
3/31/2019N/A-19-10-10N/A
12/31/2018N/A-19-9-9N/A
9/30/2018N/A-12-7-7N/A
6/30/2018N/A-14-8-8N/A
3/31/2018N/A-10-7-7N/A
12/31/2017N/A-10-7-7N/A
9/30/2017N/A-12-6-6N/A
6/30/2017N/A-9N/A-5N/A
3/31/2017N/A-9N/A-6N/A
12/31/2016N/A-6N/A-4N/A
9/30/2016N/A-5N/A-4N/A
6/30/2016N/A-3N/A-3N/A
3/31/2016N/A-2N/A-2N/A
12/31/2015N/A-2N/A-1N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 1P50 is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: 1P50 is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: 1P50 is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: 1P50's revenue (49.2% per year) is forecast to grow faster than the German market (5.1% per year).

Yüksek Büyüme Geliri: 1P50's revenue (49.2% per year) is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if 1P50's Return on Equity is forecast to be high in 3 years time

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y